Thrombophilic mutations and polymorphisms, alone or in combination, and recurrent spontaneous abortion

Clinical and Applied Thrombosis/Hemostasis

Volumn 21, Issue 4, 2015, Pages 365-372

  Lino, Fabio L ^a,b   Traina, Évelyn ^a   Barreto, José Augusto ^b   Moron, Antonio Fernandes ^a   Mattar, Rosiane ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratório de Espectrometria de Massas Associação Beneficente de Coleta de Sangue   (Brazil)

Author keywords

gene polymorphisms; gynecology and obstetrics; recurrent abortion; thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; PLASMA PROTEIN;

ADULT; ARTICLE; BRAZILIAN; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT ABORTION; RECURRENT SPONTANEOUS ABORTION; SPONTANEOUS ABORTION; THROMBOPHILIA; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; MALE; MULTICENTER STUDY; MUTATION; PREGNANCY;

ABORTION, HABITUAL; ADULT; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; THROMBOPHILIA;

EID: 84933034385     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613520465     Document Type: Article

References (53)

1. Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009 ; 92 (5). 1520-1524
2. Traina E, Daher S, Moron AF, Sun SY, Franchim CS, Mattar R. Polymorphisms in VEGF, progesterone receptor and IL-1 receptor genes in women with recurrent spontaneous abortion. J Reprod Immunol. 2011 ; 88 (1). 53-57
3. Daher S, Shulzhenko N, Morgun A, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol. 2003 ; 58 (1). 69-77
4. McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol. 2012 ; 24 (4). 229-234
5. Vora S, Shetty S, Khare M, Ghosh K. Placental histomorphology in unexplained foetal loss with thrombophilia. Indian J Med Res. 2009 ; 129 (2). 144-149
6. Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003 ; 9 (3). 331-337
7. Lay AJ, Liang Z, Rosen ED, Castellino FJ. Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities. J Clin Invest. 2005 ; 115 (6). 1552-1561
8. Gardiner C, Cohen H, Austin SK, Machin SJ, Mackie IJ. Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J Thromb Haemost. 2006 ; 4 (12). 2724-2726
9. Kim H, Cho C, Cho Y, Cho S, Yoon K, Kim K. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head. BMC Musculoskelet Disord. 2011 ; 12: 160
10. Satra M, Samara M, Wozniak G, et al. Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Pharmacogenomics. 2011 ; 12 (2). 195-203
11. Wittke Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet. 2005 ; 76 (6). 967-986
12. Bennett SA, Bagot CN, Arya R. Pregnancy loss and thrombophilia: the elusive link. Br J Haematol. 2012 ; 157 (5). 529-542
13. Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF. Factor V leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod. 1999 ; 14 (10). 2448-2450
14. Couto E, Barini R, Zaccaria R, et al. Association of anticardiolipin antibody and C677 T in methylenetetrahydrofolate reductase mutation in women with recurrent spontaneous abortions: a new path to thrombophilia?. Sao Paulo Med J. 2005 ; 123 (1). 15-20
15. Pihusch R, Buchholz T, Lohse P, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol. 2001 ; 46 (2). 124-131
16. Altintas A, Pasa S, Akdenis N, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007 ; 86 (10). 727-731
17. Abu-Asab NS, Ayesh SK, Ateeq RO, Nassar SM, El-Sharif WA. Association of inherited thrombophilia with recurrent pregnancy loss in palestinian women. Obstet Gynecol Int. 2011 ; 2011: 689684
18. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003 ; 361 (9361). 901-908
19. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006 ; 132 (2). 171-196
20. Hussein AS, Darwish H, Shelbayeh K. Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women. Thromb Res. 2010 ; 126 (2). e78 - e82
21. Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010 ; 115 (1). 5-13
22. Rodger MA, Betancourt MT, Clark P, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancycomplications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med. 2010 ; 7 (6). e1000292
23. Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010 ; 115 (1). 14-20
24. Ivanov PD, Komsa-Penkova RS, Konova EI, Kovacheva KS, Simeonova MN, Popov JD. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagul Fibrinolysis. 2009 ; 20 (2). 134-140
25. Serrano F, Lima ML, Lopes C, Almeida JP, Branco J. Factor V Leiden and prothrombin G20210A in Portuguese women with recurrent miscarriage: is itworthwhile to investigate?. Arch Gynecol Obstet. 2011 ; 284 (5). 1127-1132
26. Settin A, Alkasem R, Ali E, ElBaz R, Mashaley AM. Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss. Hematology. 2011 ; 16 (1). 59-63
27. Mtiraoui N, Zammiti W, Ghazouani L, et al. Methylenetetrahydrofolate reductase C677 T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction. 2006 ; 131 (2). 395-401
28. Kim NK, Choi YK, Kang MS, et al. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent apontaneous abortion. Thromb Res. 2006 ; 117 (6). 653-658
29. Nelen WLDM, Blom HJ, Steegers EAP, den Heijer M, Eskes TKAB. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000 ; 74 (6). 1196-1199
30. Wiwanitkit V. Roles of methylenetetrahydrofolate reductase C677 T polymorphism in repeated pregnancy loss. Clin Appl Thromb Hemost. 2005 ; 11 (3). 343-345
31. Holmes ZR, Regan L, Chilcott I, Cohen H. The C677 T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol. 1999 ; 105 (1). 98-101
32. Goodman CS, Coulam CB, Jeyendran R, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?. Am J Reprod Immunol. 2006 ; 56 (4). 230-236
33. Yenicesu GI, Cetin M, Ozdemir O, et al. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010 ; 63 (2). 126-136
34. Jeddi-Tehrani M, Torabi R, Mohammadzadeh A, et al. Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss. Am J Reprod Immunol. 2010 ; 64 (3). 212-217
35. Mukhopadhyay R, Saraswathy KN, Ghosh PK. MTHFR C677 T and factor V Leiden in recurrent pregnancy loss: a study among an endogamousgroup in North India. Genet Test Mol Biomarkers. 2009 ; 13 (6). 861-865
36. Nair RR, Khanna A, Singh K. MTHFR C677 T polymorphism and recurrent early pregnancy loss risk in north Indian population. Reprod Sci. 2012 ; 19 (2). 210-215
37. Hohlagschwandtner M, Unfried G, Heinze G, Huber JC, Nagele F, Tempfer C. Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. Fertil Steril. 2003 ; 79 (5). 1141-1148
38. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specif gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006 ; 55 (5). 360-368
39. Sotiriadis A, Makrigiannakis A, Stefos T, Paraskevaidis E, Kalantaridou S. Fibrinilytic defects and recurrent miscarriage. Obstet Gynecol. 2007 ; 109 (5). 1146-1155
40. Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran R. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol. 2008 ; 60 (5). 426-431
41. Bae J, Choi DH, Kang MS, Cha SH, Oh D, Kim NK. Effect of methylenetetrahydrofolate reductase and thymidylate synthase enhancer region polymorphisms on the risk of idiopathic recurrent spontaneous abortion in a Korean population. Fertil Steril. 2009 ; 91: 1560-1562
42. Vora S, Shetty S, Ghosh K. Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagul Fibrinolysis. 2008 ; 19 (6). 581-584
43. Aarabi M, Memariani T, Arefi S, et al. Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion. J Matern Fetal Neonatal Med. 2011 ; 24 (3). 545-548
44. Jeddi Tehrani M, Torabi R, Zarnani AH, et al. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Am J Reprod Immunol. 2011 ; 66 (2). 149-156
45. Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihush R, Thaler CJ. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod. 2003 ; 18 (11). 2473-2477
46. Wolf CE, Haubelt H, Pauer HU, et al. Recurrent pregnancy loss and its relation to FV leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb. 2003 ; 33 (3). 134-137
47. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, et al. Pasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism; impaired fibrinolysis and early pregnancy loss. Clin Chem. 2003 ; 49 (7). 1081-1086
48. Schenk JF, Stephan B, Zewinger S, Speer T, Pindur G. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion. Clin Hemorheol Microcirc. 2008 ; 39 (1-4). 329-332
49. Said JM, Tsui R, Borg AJ, et al. The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women. J Thromb Haemost. 2012 ; 10 (5). 881-886
50. Barbosa HCL, Carvalho ECC, Barini R, Siqueira LH, Costa DSP, Annichino-Bizzacchi JM. Tyr204Phe and Val34Leu polymorphisms in two brazilian ethnic groups and in patients with recurrent miscarriages. Fertil Steril. 2004 ; 82 (5). 1455-1457
51. Bagheri M, Rad IA, Omrani MD, Nanbaksh F. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion. Syst Biol Reprod Med. 2011 ; 57 (5). 261-264
52. Sotiriadis A, Vartholomatos G, Pavlou M, et al. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol. 2007 ; 57 (2). 133-141
53. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 ; 141: 7S - 47S